Supplementary Methods

Strains, primers and gBlock fragments used for mutation cassettes
Strains used in this work are listed in Table S2 . PCR primers and sequences of fragments used for assembly of mutation cassette plasmids are listed in Tables S3 -S6 . Primers for Quik-Change site-directed mutagenesis are listed in Table S7 .
Strain construction
ltaE, thrB, pdxA, serA and gmhB in JK1 were replaced with a chloramphenicol resistance gene amplified by PCR from pACYC184 as previously described (1). gph was replaced in JK1 with a kanamycin resistance gene amplified by PCR from the ∆gph mutant in the Keio collection (2) . (The kanamycin resistance gene that replaced pdxB in the parental ∆pdxB::kan strain was removed prior to replacement of gph with kan using the method of Datsenko and Wanner (3) .)
A mutation that renders SerA insensitive to serine inhibition was introduced into JK1 using the scarless genome editing protocol described by Kim et al. (4) (Fig. S10) . A mutation cassette template plasmid was constructed by Gibson assembly (5) of a mutation cassette fragment with pHA1887 (a linear fragment of pUC18 amplified from pUC19 using primers pHAFor and pHArev that contains the replication origin and the bla gene conferring ampicillin resistance). The mutation cassette contained upstream and downstream homology arms targeted to serA flanking an I-SceI site followed by a chloramphenicol resistance gene. The upstream and downstream homology arms contained overlapping regions with the desired mutation. The mutation cassette was amplified from the plasmid by PCR and introduced into JK1 carrying pSLTS, a helper plasmid that encodes the Lambda Red recombinase enzymes and I-SceI (4) . The Lambda Red enzymes were induced with arabinose to catalyze recombination between the mutation cassette and the genome. Then I-SceI was induced with anhydrotetracycline to cleave the genome at the introduced I-SceI site.
Healing of the break by recombination between the upstream and downstream homology arms eliminated the antibiotic resistance gene and incorporated the desired mutation into the genome.
The resulting strain is designated serA* JK1. serC in serA* JK1 was replaced with a chloramphenicol resistance gene amplified by PCR from pACYC184 as previously described (1).
Mutations that change Gly210 to Val and Leu158 to Gln in GAPDH were introduced into the genome of wild-type E. coli K12 BW25113 using the method described in Kim et al. (4) for genome editing of essential genes. The mutation cassette in this case consisted of upstream and downstream homology arms flanking a fragment containing an I-SceI site, a chloramphenicol resistance gene, and a fragment of gapA recoded with synonymous codons. Recombination between the mutation cassette and the genome reconstituted an intact gapA (Fig. S11) . Subsequent cleavage by I-SceI and recombination between HR3 regions accomplished elimination of the antibiotic resistance gene and incorporation of the target mutation into the genome. (Recoding the gapA fragment in the mutation cassette prevented homologous recombination in the recoded region after I-SceI cleavage, which would fail to introduce the desired mutation into the genome.)
The ∆serA::cat ∆pdxB (DE3) E. coli strain used for purification of wild-type and mutant versions of SerA was constructed by replacing serA with the chloramphenicol resistance gene cat in a ΔpdxB∷kan BW25113 strain that had been lysogenized with the λ DE3 cassette (Novagen, EMD Chemicals Inc.) as described by Kim et al. (1) , followed by removal of kan as described by Datsenko and Wanner (3) . (Removal of kan was necessary to allow for selection of kanamycin resistance conferred by pEcPGDH, the expression plasmid encoding serA.)
Illumina sequencing and data analysis
The sequencing library was prepared as described by Turner et al. (6) according to the protocol of Baym et al. (7) using the Illumina Nextera kit (Illumina Inc., San Diego, CA) and sequenced using an Illumina NextSeq500 at the University of Pittsburgh Microbial Genome Sequencing Center. Coverage ranged from 80-fold to 255-fold for individual clones. BBTools (https://sourceforge.net/projects/bbmap/) were used to remove adapters and unbin the quality scores from the Illumina NextSeq results. Reads were mapped to the K12 BW25113 reference genome (GenBank CP009273.1) (8) using Breseq (9) with default parameters.
Purification of SerA, SerC and ThrB
pEcPGDH, which encodes SerA with a His6-tag at the N terminus, was a generous gift from the laboratory of Gregory Grant. The wild-type serA in pEcPGDH was replaced with mutant serA alleles amplified by PCR from adapted strains containing serA mutations for expression of mutant versions of SerA. thrB was cloned into pET45b (EMD Biosciences Inc.), which results in incorporation of a His6 tag at the N-terminus of the protein. serC was cloned into pET21b (Novagen) which results in incorporation of a His6 tag at the C-terminus of the protein.
SerC and ThrB were expressed in E. coli BL21(DE3). SerA enzymes were expressed in ∆serA ∆pdxB E. coli DE3 to prevent contamination with wild-type SerA and PdxB.
Purification of SerC, ThrB and SerA was carried out as follows. A single colony from a fresh LB plate was inoculated into 3 mL LB containing 20 µg/mL kanamycin for expression of SerA and 100 µg/mL ampicillin for expression of ThrB and SerC. The culture was grown at 37 ºC overnight with shaking and then inoculated into 300 mL LB containing 20 µg/mL kanamycin or 100 µg/mL ampicillin. After growth with shaking at 37 ºC to an OD600 of 0.5, the culture was cooled to room temperature, and 0.2 mM IPTG was added to induce protein expression. The culture was shaken at 22 ºC for 16 hours and then harvested by centrifugation at 5000 x g at 4 ºC for 15 minutes. The cell pellet was suspended in 5 volumes of Equilibration Buffer (20 mM sodium phosphate, pH 7.4, containing 300 mM NaCl and 10 mM imidazole). Protease inhibitor cocktail (Sigma P8849) (1 mL/g wet cell pellet) and lysozyme (1 mg/mL) were added and the cells were shaken gently at 22 ºC for 10 minutes. The cells were then lysed in an ice bath by 3-5 cycles of sonication using 20 pulses at a 50% pulse rate and intensity setting of 4/10. The lysed cells were centrifuged at 20,000 x g at 4 ºC for 15 minutes to remove cell debris. Proteins were Analysis of the purified proteins by SDS-PAGE indicated that they were approximately 80% pure.
Purification of wild-type and mutant GAPDH enzymes
Wild-type gapA was cloned into pET46 using a pET46/LIC vector kit (Novagen) so as to introduce an N-terminal His tag. Mutant gapA genes encoding G210V and L158Q GAPDH were generated using a QuikChange II Site-Directed Mutagenesis kit (Agilent) and the primers listed in Table S7 .
His-tagged wild-type and variant GAPDH enzymes were expressed in E. cloni Analysis of the purified proteins by SDS-PAGE indicated that they were approximately 95% pure.
Enzyme assays
GAPDH activity of purified enzymes was assayed at 37 ºC in 40 mM triethanolamine, pH 8.9, containing 50 mM potassium phosphate, 1 mM NAD + and variable amounts of glyceraldehyde 3-phosphate (0-0.5 mM). The reaction was initiated by addition of glyceraldehyde 3-phosphate and the initial absorbance change due to reduction of NAD + (e340 = 6.2 mM -1 cm -1 ) (10) was monitored. GAPDH activity was also assayed in crude lysates prepared by sonication of cells harvested from overnight cultures grown in LB medium. Protease inhibitor cocktail (Sigma P8849) was added prior to sonication (3 20-second pulses separated by one-minute cooling on ice). The cell lysates were subjected to centrifugation for 1 minute at 3900 x g. One mL of the supernatant was concentrated 10-fold in an Amicon® Ultra-4 Centrifugal Filter Units at 300 x g for 10 minutes and then diluted with 900 µL of 50 mM sodium phosphate, pH 7.2, and reconcentrated twice to 100 µL in order to exchange the buffer. GAPDH activity was assayed at 37 ºC in 50 mM sodium phosphate, pH 7.2, containing 1 mM NAD + and variable amounts of glyceraldehyde 3-phosphate (0-2 mM).
SerA activity was assayed at 37 ºC using the coupled enzymatic assay shown in 
SerC activity ( Fig. S13) mixtures were incubated at 37 °C for 24 hours before 31 P-NMR analysis at room temperature using 4096 scans on a Bruker Avance-III 300 MHz spectrometer.
Proteomics
Freezer stocks were used to streak each strain on LB plates (wild-type and G210V gapA mutants) or LB plates containing 20 µg/mL kanamycin (JK1). Four parallel 2-mL aliquots of LB (containing 20 µg/mL kanamycin for JK1) were inoculated with individual colonies and the cultures were grown to mid-exponential phase at 37 °C with shaking. One mL of each culture was subjected to centrifugation at 16,000 x g for 1 min at room temperature. The cell pellets were resuspended in 1 mL PBS and washed twice more in PBS before resuspension and dilution to an OD of 0.001 in 5 mL of M9/glucose (0.4%). Cultures were grown to an OD600 of 0.2-0.3 at 37 °C with shaking and then chilled on ice for 10 min. Two mL of each culture was subjected to centrifugation at 4,000 x g at 4 °C. Cell pellets were frozen in liquid N2 and stored at -70 °C.
Frozen cell pellets were thawed and lysed in 60 µL 50 mM Tris-HCl, pH 8. 
Metabolomics
Intracellular metabolites were extracted using a glycerol/saline quenching protocol (13, 14) . Twenty-five mL cultures were grown in M9/glucose (0.4%) to an OD600 of 0.5. Using pipettes prewarmed to 37 °C, 10 mL of culture were transferred rapidly into 30 mL of Quenching Solution (60% v/v glycerol, 0.54% w/v NaCl) kept at -20 ºC with a 70% ethanol bath. The tube was inverted to mix. Samples were subjected to centrifugation at 29,000 x g for 20 min at -10 °C and the To quantify total biomass in each sample, the cell pellet remaining after metabolite extraction was resuspended in 50 µL 0.2 M sodium hydroxide and incubated at 100 ºC for 20 minutes. Samples were cooled on ice, then subjected to centrifugation for 5 minutes at 2,500 x g to remove the precipitate. The protein concentration in the supernatant was measured using a Qubit protein assay (Thermoscientific Q33211) according to the manufacturer's instructions. (15) . The raw data were processed and analyzed by custom software using Matlab (Mathworks). Fig. S1 . Details of the process of adaptation of 12 parallel lineages of ∆pdxB E. coli in M9/glucose (0.4%). Reproduced from (4), published by Springer Nature. Table S3 . Fragments used to assemble mutation cassette plasmids. These fragments were assembled into a mutation cassette plasmid by Gibson assembly with the vector backbone (pHA1887) and a fragment encoding a double transcription terminator followed by an I-SceI site and a chloramphenicol resistance gene (4 Legends for Datasets S1 to S3 Dataset 1. Mutations found in evolved strains.
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Dataset 2.
Abundances of targeted metabolites in lysates of wild-type E. coli, JK1, and strains in which mutations generating G210V GAPDH had been introduced.
Dataset 3.
Abundances of 1790 proteins in JK1 and wild-type E. coli.
